Discover Hope with Spravato® Therapy
Discover the life-changing potential of Spravato® therapy, an FDA-approved treatment for depression.
What is Spravato®?
Spravato® (esketamine) is an FDA-approved prescription nasal spray designed for adults with treatment-resistant depression. Unlike traditional antidepressants, which can take weeks to work, Spravato® targets a different pathway in the brain and may provide rapid relief for some patients.
How Spravato® is Administered
Administered under medical supervision, this innovative treatment offers new hope for those who haven’t found success with other therapies.
SPRAVATO® is only available through a restricted program called the SPRAVATO® REMS (5.5).
What is Esketamine?
Esketamine is a fast-acting, FDA-approved medication derived from ketamine, used to treat treatment-resistant depression by targeting new pathways in the brain.
